NUTM1 and nevus comedonicus syndrome: Using outcomes and NUTM1 fusion identities from this largest cohort of NC patients with available data, we sought to identify clinically and molecularly distinct subsets of NC patients with statistically significantly different prognosis based on OS using survival tree regression (see Supplementary Methods and Supplementary Table 2, available online).